The immunopathogenesis of autoimmune pancreatitis (AIP) is poorly understood. 
| INTRODUCTION
Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis (CP). It is a differential diagnosis of pancreatic carcinoma, because clinical symptoms of both entities are very similar. 1 However, the specific therapeutic requirements differ: while surgery is the only potentially curative therapy for pancreatic carcinoma, patients suffering from AIP respond well to steroids, 2 a treatment that is ineffective in the more common forms of CP.
Both, humoral and cellular immunity have been implicated into the pathogenesis of AIP. 3 Nevertheless, the cellular and molecular basis of this disease remains largely unknown. The humoral immune response has been in focus recently, but still it is incompletely understood. Several autoantibodies, for example anti-carbonic anhydrase-II, anti-lactoferrin and antitrypsinogen, have been found in the serum of AIP patients. 4 However, whether autoantibodies have an active role in the pathogenesis of AIP or are an epiphenomenon remains unclear. Furthermore, for a subgroup of AIP cases, elevated levels of immunoglobulin (Ig)-G4 in serum and dense infiltrates of IgG4-positive plasma cells in the tissue are pathognomonic. This entity, termed AIP type 1, has recently been defined as the pancreatic manifestation of IgG4-related disease (IgG4-RD). [5] [6] [7] In contrast, AIP type 2 is characterized by granulocyte epithelial lesions (GELs) and the absence of IgG4-positive cells.
Less is known about cellular immune processes in AIP, although T cells are the prevalent type of infiltrating immune cells in affected tissue. 8, 9 Both, CD4 + and CD8 + T lymphocytes are present in pancreatic parenchyma of AIP patients, 3 but CD4 + T cells predominate in tissue infiltrates. Increased production of interferon (IFN)-c by CD4 + T helper -cells type 1 (Th1) has been proposed to promote AIP, 8 and treatment with IFN-c strongly aggravated AIP in mice. 10 On the other hand, cytokines promoting the development of Th2 have also been described in the context of AIP.
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The MRL/MpJ mouse model has proven useful to study the pathogenesis of AIP. These mice spontaneously develop an AIP at the age of about 6 months. 12, 13 The murine AIP histopathologically resembles the human AIP type 1. The incidence and the severity of the disease are higher for female than for male mice and can be triggered using polyinosinic:polycytidylic acid (poly I:C).
14 Using this mouse model in previous studies, we gained genetic evidence for an involvement of CD4 + CD44 high memory T cells in the pathogenesis of AIP. 15 Likewise, our studies implicated regulatory T cells (T regs ) in the mediation of the therapeutic effects of rapamycin through a suppression of the effector T cell response. Six weeks after cell injection, the mice were sacrificed, serum was collected, and the pancreas, liver and kidneys were cryo-and paraffin-embedded for further analyses. The workflow for the adoptive transfer is illustrated in Figure 1 . On day 7, the MACSiBeads were removed employing the MACSiMAG Seperator (Miltenyi Biotec) and cells were sowed out again with fresh beads. The expansion was repeated for another week.
| Isolation, expansion and adoptive transfer of regulatory T cells
After a total of 14 days, the beads were removed again and the cells were resuspended in PBS, pH 7.4. 2.5 9 10 6 cells in a volume of 200 lL were injected into the tail vain of 30 AE 0.2-week-old female MRL/MpJ mice (pretreated with cyclophosphamide as described above; for workflow, see Figure 1 ). Mice (29 AE 0.2 weeks old) that were not treated with cells served as controls. End-point analyses for both groups were carried out 6 weeks after cell injection.
| Histology and immunohistochemistry
Paraffin-embedded pancreatic sections were stained with haematoxylin and eosin (H&E), and pathological changes were graded on a semi-quantitative scale from 0 (none) to 4 (severe) as previously described (H&E-score). 
| Statistical evaluations

| CD3 + T cells effectively transfer murine AIP
For the adoptive transfer of splenocytes, the cells acquired from donor MRL/MpJ mice were cultured for 3 days before CD3 + , CD4 + or CD8 + T cells were purified. All isolations lead to highly pure cell populations ( Figure S1 ). Either one of the isolated subpopulations or unpurified splenocytes were then transferred into young and still healthy female MRL/MpJ recipient mice (Table 1) . Additionally, unpurified splenocytes were also transferred into male recipient mice. Young female MRL/MpJ mice that were not treated with cells served as a control group. Six weeks after the cell injection, the AIPscore of the recipient mice was evaluated ( Figure 3 ).
As expected, both animals of the control group and male recipient mice exhibited autoimmune lesions at a low frequency only (average AIP-scores: control group 0.7 AE 0.2, male recipients were not significantly higher than the score of untreated controls. 
| Composition of inflammatory foci
| Other organ involvements
AIP of MRL/MpJ mice is occasionally accompanied by autoimmune lesions in liver and kidney (Ref. [9] and Figure 5 ). Investigating control mice and recipients of unpurified splenocytes and CD3 + T cells from adult mice with AIP, we observed autoimmune foci in these organs in 10%-30% of the animals ( Figure 5 and Figure S2 ). There . Six weeks after cell injection, the mice were sacrificed, the pancreata were CD3 and H&E stained and subjected to semi-quantitative evaluation (scores from 0 to 4). Data are presented as mean AE SEM (n = 6-10 per group; Table 1 ), *P < .05 vs untreated controls were no significant differences between treated mice and controls.
Therefore, under the given experimental conditions, the injected cells did not have an impact on other vulnerable organs than the pancreas. Figure 3 ). Data are presented as mean AE SEM (n = 9-10 per group), *P < .05 vs untreated controls Regulatory T cells are immune cells with largely inhibitory characteristics. 11 The specific role of these cells in AIP, however, remains to be elucidated. In MRL/MpJ mice, the therapeutic effect of rapamycin could be linked to the activation of T regs , which suppress the activity of effector T cells. 9 This suppressive effect of 3, 13, 16, 22 As a major limitation of any mouse model of AIP, the lack of IgG4 has to be taken into account. The relevance of our findings for the human situation therefore needs to be studied further.
While this study was dedicated to the analysis of the role of different T cell populations, previous experimental studies by us and others have implicated macrophages (particularly, of the M1 subtype) and neutrophils into the pathogenesis of the disease. 9, 10, 12, 13, 16 Specifically, it has been proposed that activated macrophages may induce destruction of pancreatic parenchyma directly or via antibody-dependent cellular cytotoxicity. 12 and SI (IB 24/9-1).
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